山東博安生物技術股份有限公司（06955）於2025年12月3日公佈2025年11月結束之股份變動月報表。報告顯示，截至2025年11月30日，公司註冊股本維持在人民幣622,333,694元，無任何新增發行、購回或註銷股份，已發行股份總數仍為622,333,694股。
根據公告，普通股H股在報告期內未有變動，各類股本數量與上月結存相同，均保持穩定。公司亦未有期權、權證或可換股票據相關變動，亦無其他協議或安排導致股本變動。
公司同時確認遵守香港聯合交易所有限公司《上市規則》及相關法律法規。本次公告由公司董事姜華代表董事會簽署，並表示所有數據及事項已獲正式授權及審核。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.